Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Vir Biotechnology, Inc. (VIR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/05/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 700 shares
@ $25.11, valued at
$17.6k
|
|
07/03/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 18,000 shares
@ $24.662, valued at
$443.9k
|
|
06/30/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 7,010 shares
@ $25.0958, valued at
$175.9k
Sold 89,942 shares
@ $25.1799, valued at
$2.3M
|
|
06/15/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 36,547 shares
@ $26.8058, valued at
$979.7k
Sold 70,307 shares
@ $27.2307, valued at
$1.9M
Sold 20,967 shares
@ $25.9213, valued at
$543.5k
Sold 36,281 shares
@ $26.2431, valued at
$952.1k
|
|
06/08/2023 |
4
| Pang Phillip (Chief Medical Officer) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 5,000 shares
@ $25.9454, valued at
$129.7k
Exercised 5,000 options to buy
@ $1.53, valued at
$7.7k
|
|
06/06/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 34,365 shares
@ $27.3165, valued at
$938.7k
Sold 5,197 shares
@ $27.3231, valued at
$142k
|
|
06/02/2023 |
4
| Rice Steven J. (Chief Administrative Officer) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 2,500 shares
@ $25.67, valued at
$64.2k
|
|
06/02/2023 |
4
| Ramasastry Saira (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 3,500 shares
@ $25.67, valued at
$89.8k
|
|
05/25/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 2,317 shares
@ $25.8385, valued at
$59.9k
Sold 144,402 shares
@ $26.6104, valued at
$3.8M
Sold 23,348 shares
@ $27.0159, valued at
$630.8k
Sold 35,307 shares
@ $25.8911, valued at
$914.1k
Sold 66,754 shares
@ $26.2527, valued at
$1.8M
Sold 2,323 shares
@ $27.1155, valued at
$63k
|
|
05/24/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| PEREZ ROBERT J (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| Ramasastry Saira (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| Napolitano Janet (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| MORE ROBERT J (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/24/2023 |
4
| Sigal Charles Elliott (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 6,027 shares
@ $0 Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
05/23/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 91,651 shares
@ $25.3814, valued at
$2.3M
Sold 91,896 shares
@ $25.7237, valued at
$2.4M
|
|
05/09/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 136 shares
@ $25.1032, valued at
$3.4k
|
|
05/05/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 83,674 shares
@ $25.512, valued at
$2.1M
Sold 114,332 shares
@ $25.5498, valued at
$2.9M
|
|
05/03/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 3,075 shares
@ $25.3047, valued at
$77.8k
|
|
04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2023 |
4
| De Backer Marianne (CEO) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Granted 576,452 shares
@ $0 Granted 1,152,904 options to buy
@ $23.28, valued at
$26.8M
|
|
03/31/2023 |
4
| HANLY ANN M. (Chief Technology Officer) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 2,627 shares
@ $22.77, valued at
$59.8k
|
|
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 17,935 shares
@ $22.585, valued at
$405.1k
|
|
03/07/2023 |
4
| Friedl-Naderer Johanna (EVP & COO) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 1,482 shares
@ $22.82, valued at
$33.8k
|
|
03/02/2023 |
4
| Sigal Charles Elliott (Director) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Bought 2,500 shares
@ $22.7262, valued at
$56.8k
|
|
02/28/2023 |
4
| Pang Phillip (Chief Medical Officer) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 8,920 shares
@ $23.0029, valued at
$205.2k
Sold 1,400 shares
@ $23.5601, valued at
$33k
|
|
02/24/2023 |
4
| Horn Howard (CFO) has filed a Form 4 on Vir Biotechnology, Inc.
Txns:
| Sold 2,248 shares
@ $25.973, valued at
$58.4k
|
|
|
|
|